Transplantation Proceedings

• 

  Publication Venue For

  • Surgical Dead End in a Renal Transplant Recipient Associated With a Rare Thrombohemorrhagic Syndrome..  47:2537-2540. 2015
  • Acute Kidney Injury After Ex Vivo Lung Perfusion (EVLP).  46:3598-3602. 2014
  • Reversible cardiomyopathies--a review..  42:3673-3678. 2010
  • Ex Vivo Transfer of Nuclear Factor-κB Decoy Ameliorates Hepatic Cold Ischemia/Reperfusion Injury.  41:1504-1507. 2009
  • Composite tissue allotransplantation: past, present and future-the history and expanding applications of CTA as a new frontier in transplantation..  41:463-465. 2009
  • Current indications for hand and face allotransplantation..  41:495-498. 2009
  • Increased signs of acute rejection with ischemic time in a rat musculocutaneous allotransplant model..  41:531-536. 2009
  • The history of human composite tissue allotransplantation..  41:466-471. 2009
  • A nuclear factor-kappaB inhibitor BAY11-7082 inhibits interactions between human endothelial cells, T cells, and monocytes..  40:2724-2728. 2008
  • CD4+ T-cell and monocyte interdependence during discordant xenoimmune responses..  40:2764-2768. 2008
  • Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium..  40:2729-2733. 2008
  • Rabbit anti-human leukocyte polyclonal antibody inhibits xenogeneic cell-mediated immune responses..  40:2760-2763. 2008
  • Reduced antigenicity of formaldehyde-fixed arterial allografts and their potential clinical application..  40:2750-2754. 2008
  • Conversion from mycophenolate mofetil to azathioprine in renal allograft [corrected] patients within the first month posttransplantation..  40:2258-2261. 2008
  • Molecular characterization of hypoxia-hypothermia-conditioned human endothelial cells and their interaction with human monocytes..  40:2127-2135. 2008
  • A new swine training model of hand-assisted donor nephrectomy..  40:2035-2037. 2008
  • Endolymphatic immunotherapy in inoperable hepatocellular carcinoma..  40:1913-1915. 2008
  • Extracorporeal portal vein oxygenation improves outcome of acute liver failure in swine..  40:2046-2048. 2008
  • Kidney transplantation combined with other organs in Bologna: an update..  40:1867-1868. 2008
  • Composite tissue transplantation: a rapidly advancing field..  40:1237-1248. 2008
  • Donor Age in Living Donor Liver Transplantation.  40:1471-1475. 2008
  • Estimation of Standard Liver Volume for Japanese Adults.  40:1456-1460. 2008
  • Are we ready to utilize non-heart-beating donors for clinical allotransplantation in China?.  40:1018-1020. 2008
  • Simultaneous bilateral lung and pancreas transplantation in recipient with cystic fibrosis..  40:494-497. 2008
  • The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C..  40:219-223. 2008
  • Successful ABO Incompatible Living Donor Liver Transplantation in a Patient With High Isoagglutinin Titer Using High-Dose Intravenous Immunoglobulin.  39:3491-3494. 2007
  • Bologna transplant center results in double kidney transplantation: update..  39:1833-1834. 2007
  • Portal vein arterialization in hepatobiliary surgery and liver transplantation..  39:1877-1878. 2007
  • Protective effect of an inhibitor of interleukin-8 (meraxin) from ischemia and reperfusion injury in a rat model of kidney transplantation..  39:1771-1772. 2007
  • Insulin secretion from pancreatic islets in fibrin glue clots at different fibrinogen and thrombin concentrations..  39:1607-1608. 2007
  • Hyperlipidemia after renal transplantation and its relation to graft and patient survival..  39:1044-1047. 2007
  • Protective effect of portal vein arterialization in acute liver failure induced by hepatectomy in normal and fatty liver rat..  38:3249-3250. 2006
  • Predicting outcome of procedures to slow intestinal transit..  38:1838-1839. 2006
  • Effect of age on outcomes after left ventricular assist device placement..  38:1496-1498. 2006
  • Portal vein arterialization for the treatment of post resection acute liver failure in the rat..  38:1185-1186. 2006
  • Portal vein oxygen supply through a liver extracorporeal device to treat acute liver failure in Swine induced by subtotal hepatectomy: preliminary data..  38:1190-1192. 2006
  • Successful treatment of CCL4-induced acute liver failure with portal vein arterialization in the rat..  38:1187-1189. 2006
  • Technical aspects of portal vein arterialization for acute liver failure: from rat lab to man..  38:1195-1197. 2006
  • Lambda light chain deposition disease in a renal allograft..  37:4289-4292. 2005
  • Obesity predicts increased overall complications following pancreas transplantation..  37:3564-3566. 2005
  • Oral feeding with pig peripheral lymphocytes decreases the xenogeneic delayed type hypersensitivity reaction in galactosyltransferase knockout mice..  37:3327-3331. 2005
  • Liver retransplantation: a single-center outcome and financial analysis..  37:1161-1163. 2005
  • Living Donor Liver Transplantation for Hepatocellular Carcinoma: A Special Reference to a Preoperative Des-Gamma-Carboxy Prothrombin Value.  37:1177-1179. 2005
  • 17beta-estradiol differentially activates mitogen-activated protein-kinases and improves survival following reperfusion injury of reduced-size liver in mice..  37:399-403. 2005
  • S100β protein: The preoperative new clinical indicator of brain damage in patients with fulminant hepatic failure.  36:2713-2716. 2004
  • Accurate method for clinical assessment of right lobe liver weight in adult living-related liver transplant.  36:1429-1433. 2004
  • Tolerance mechanisms and recent progress..  36:561S-569S. 2004
  • Risks and benefits of nucleosides before and after liver transplantation..  35:2086-2087. 2003
  • A case of electrical storm in a liver transplant patient..  35:1437-1438. 2003
  • A simple new formula to assess liver weight.  35:1415-1420. 2003
  • Sirolimus monotherapy following Campath-1H induction..  35:128S-130S. 2003
  • Involvement of linker for activation of T cells in the costimulatory signaling pathways..  35:553-554. 2003
  • Intravenous fluid therapy in renal transplant recipients: results of a US survey..  34:3142-3145. 2002
  • CD62-PSGL-1 interactions regulate cytokine chemokine and apoptotic networks in cardiac allograft recipients..  34:1463-1464. 2002
  • Assessment of quality of life after pediatric intestinal transplantation by parents and pediatric recipients using the child health questionnaire..  34:963-964. 2002
  • Basiliximab decreases the incidence of acute rejection after intestinal transplantation..  34:940-941. 2002
  • Campath-1H in intestinal and multivisceral transplantation: preliminary data..  34:937. 2002
  • Initial experience using rapamycin immunosuppression in pediatric intestinal transplant recipients..  34:934-935. 2002
  • Intestinal transplantation at the University of Nebraska Medical Center: 1990 to 2001..  34:958-960. 2002
  • Oral beclomethasone therapy for recurrent small bowel allograft rejection and intestinal graft-versus-host disease..  34:938-939. 2002
  • Utilization and tailoring of interventional radiology procedures in small bowel transplants..  34:929-930. 2002
  • Perioperative donor bone marrow infusion in cadaver kidney transplant recipients..  33:3840-3843. 2001
  • Steps toward transplantation tolerance in the clinic..  33:3844-3845. 2001
  • Successful hepatitis B reinfection prophylaxis with lamivudine and hepatitis B immune globulin in patients with positive HBV-DNA at time of liver transplantation..  33:3637-3638. 2001
  • Blockade of the CD40 pathway fails to prevent CD8 T cell-mediated intestinal allograft rejection..  33:418-420. 2001
  • Cytokine genotypes in kidney, heart, and lung recipients: consequences for acute and chronic rejection..  33:489-490. 2001
  • Donor bone marrow infusions are tolerogenic in human renal transplantation..  33:1295-1296. 2001
  • Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model..  33:223-224. 2001
  • Primate skin allotransplantation with anti-CD154 monotherapy..  33:675-676. 2001
  • Results of solitary pancreas transplantation with enteric drainage: is there a benefit from monitoring urinary amylase levels?.  33:1700. 2001
  • Significance of cytokine gene polymorphism in renal transplantation..  33:483-484. 2001
  • Assessment of function, growth and development, and long-term quality of life after small bowel transplantation..  32:1211-1212. 2000
  • Incidence, timing, and histologic grade of acute rejection in small bowel transplant recipients..  32:1199. 2000
  • Intestinal transplantation: a single-center experience..  32:1228. 2000
  • Isolated liver transplantation in infants with total parenteral nutrition-associated end-stage liver disease..  32:1241. 2000
  • Evidence of immunocomplex formation in pulmonary xenografts..  32:1141. 2000
  • Surrogate tolerogenesis: possible pretransplant induction of accommodation of pig xenografts..  32:994-995. 2000
  • Graft hyporeactivity induced by donor-derived dendritic cell progenitors..  32:260-264. 2000
  • Effect of anti-lymphocyte antibody induction therapy on renal allograft survival..  31:9S-11S. 1999
  • Inducing unresponsiveness by the use of anti-CD3 immunotoxin, CTLA4-Ig, and anti-CD40 ligand..  31:27S-28S. 1999
  • Involvement of protein tyrosine phosphorylation in immunotoxin effects on T lymphocytes..  31:785. 1999
  • Inducing unresponsiveness by the use of anti-CD3 immunotoxin, CTLA4-Ig, and anti-CD40 ligand.  31:27S-28S. 1999
  • Synchronous intestinal transplantation inhibits post resection adaptation..  30:2634-2635. 1998
  • Incidence of cytomegalovirus disease in renal transplantation without antilymphocyte induction: is prophylaxis necessary?.  30:2097-2099. 1998
  • Reversal of acute allograft rejection using immunotoxin..  30:2150-2151. 1998
  • Long-term outcomes in simultaneous kidney-pancreas transplant recipients..  30:1564-1565. 1998
  • Immunophenotyping and cellular immune responses of cadaveric donor bone marrow cells..  30:727-728. 1998
  • Donor factors affecting outcome after pancreas transplantation..  30:276-277. 1998
  • Enteric conversion of bladder-drained pancreas allografts: experience in 95 patients..  30:441-442. 1998
  • Immunologic risks of combined kidney-pancreas transplantation..  30:249-250. 1998
  • Long-term outcomes in simultaneous kidney-pancreas transplantation..  30:290. 1998
  • Transplantation of feline islets of Langerhans in the subretinal space of cat eyes..  30:593-595. 1998
  • Extending the boundaries of acceptable organ donors: a means of expanding the donor pool for liver transplantation..  29:3288. 1997
  • Inhibition of the inositol triphosphate receptor increases endotoxin-mediated nitric oxide synthesis in macrophages..  29:2569-2570. 1997
  • Causes of late mortality in pediatric liver transplant recipients..  29:430-431. 1997
  • Correlation of serologic and urinary tests with allograft biopsy in the diagnosis of pancreas rejection..  29:673. 1997
  • Identification of poorly performing transplant centers using the UNOS center-specific data..  29:1495. 1997
  • Influence of donor base deficit status on recipient outcomes in liver transplantation..  29:474. 1997
  • Long-term follow-up of auxiliary liver transplantation for fulminant hepatic failure..  29:485-486. 1997
  • Mechanisms of tolerance induced by an immunotoxin against CD3 epsilon in a rhesus kidney allograft model..  29:1158. 1997
  • Overcoming rejection in pig-to-primate cardiac xenotransplantation..  29:938-939. 1997
  • Retransplantation in the diabetic with a pancreas allograft after previous kidney or pancreas transplant..  29:666. 1997
  • The evaluation of thrombomodulin activity in porcine to human xenotransplantation..  29:884-885. 1997
  • Gene therapy and transplantation - A brief review.  28:19-23. 1996
  • Gene therapy and transplantation - A brief review.  28:19-23. 1996
  • Gene therapy and transplantation--a brief review..  28:19-23. 1996
  • Identical twin small bowel transplant after resection of abdominal desmoid tumor..  28:2731-2732. 1996
  • Intestinal transplantation: the University of Wisconsin experience..  28:2740-2741. 1996
  • Public preferences for efficiency and racial equity in kidney transplant allocation decisions..  28:2997-3002. 1996
  • Systemic inflammatory response syndrome after human syngeneic intestinal transplantation: evidence for disruption of enterocyte barrier function..  28:2763-2764. 1996
  • Living related donor liver transplantation at the University of Nebraska Medical Center (1996)..  28:2382. 1996
  • Long-term pancreatic function: potential benefits..  28:2128-2130. 1996
  • Preoperative estimation in living related donor transplantation: clinical correlation and donor/recipient ratio..  28:2370. 1996
  • The potential of xenotransplants..  28:2024-2025. 1996
  • Graft-versus-host reactions: anti-leukemia effects of donor T cells..  28:1184-1185. 1996
  • A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients..  28:917-918. 1996
  • Characterization of xenoreactive natural antibodies: interactions with carbohydrate determinants..  28:548. 1996
  • Continuous complement (C) inhibition using soluble C receptor type 1 (sCR1): effect on hyperacute rejection (HAR) of pig-to-primate cardiac xenografts..  28:756. 1996
  • FK 506 induction and rescue therapy in pancreas transplant recipients..  28:991-992. 1996
  • Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy..  28:943-944. 1996
  • Identification and characterization of a peptide mimeotope of galactose alpha 1,3 galactose..  28:554. 1996
  • Phenotype of infiltrating cells in an ex vivo model of human antiporcine hyperacute cardiac xenograft rejection..  28:777. 1996
  • Porcine endothelial cell membrane antigens recognized by human and baboon xenoreactive antibodies during organ perfusion..  28:607. 1996
  • The humoral immune response in humans following ex vivo perfusion of porcine livers..  28:546. 1996
  • The role of C3a and C5a in hyperacute rejection of guinea pig-to-rat cardiac xenografts..  28:596. 1996
  • Variation in expression of biologically reactive xenoantigen does not correlate with expression of Gal alpha (1-3)Gal..  28:555. 1996
  • Xenoreactive natural antibodies and isohemagglutinins: a distinct class of antibodies..  28:573. 1996
  • A comparison of the sensitivities of contrast and isotope voiding cystourethrograms for the detection of pancreas transplant bladder leaks..  27:3143-3144. 1995
  • Clinical and laboratory features of pancreatic transplant bladder leaks..  27:3141-3142. 1995
  • Diagnosis and treatment of symptomatic peripancreatic fluid collections after pancreas transplant..  27:3057-3058. 1995
  • Experience with enteric conversion after pancreas transplantation with bladder drainage..  27:3014-3015. 1995
  • Experience with pancreas retransplantation..  27:3020-3021. 1995
  • Experience with protocol biopsies after solitary pancreas transplantation..  27:3012-3013. 1995
  • Increased risk of pulmonary edema in diabetic patients undergoing preemptive pancreas transplantation with OKT3 induction..  27:3016-3017. 1995
  • Infection prophylaxis in pancreas transplant recipients..  27:3018-3019. 1995
  • Is there a transfusion effect in combined pancreas-kidney transplantation?.  27:3096. 1995
  • Preliminary experience with FK 506 in pancreas transplant recipients..  27:3024. 1995
  • Solitary pancreas transplantation: experience with 50 consecutive cases..  27:3022-3023. 1995
  • Right ventricular dysfunction in the brain-dead heart-beating organ donor..  27:2551-2555. 1995
  • Controlled non-heart-beating donors: a potential source of extrarenal organs..  27:707-709. 1995
  • Immunopathology of porcine livers perfused with blood of humans with fulminant hepatic failure..  27:280-281. 1995
  • Prevention of hyperacute xenograft rejection by intravenous immunoglobulin..  27:271. 1995
  • An effective strategy for decontamination, ex vivo expansion, and storage of human fetal liver hematopoietic stem cells..  26:3352-3353. 1994
  • Human fetal liver hematopoietic cell expansion with a novel bioreactor system..  26:3338-3339. 1994
  • Antifungal effects of cyclosporine and FK 506 are mediated via immunophilin-dependent calcineurin inhibition..  26:2833-2834. 1994
  • Cyclosporine increases hepatocyte synthesis of the immunosuppressive free radical nitric oxide..  26:2910-2911. 1994
  • Erythroid-specific expression of human CD59 and transfer to vascular endothelial cells..  26:1241. 1994
  • Survival of guinea pig cardiac xenografts in C6-deficient PVG rats treated with monoclonal antibody to CD18..  26:1251. 1994
  • Water, sodium, potassium, and D-xylose absorption in canine small bowel transplantation..  26:1661. 1994
  • Clinical pancreas preservation and transplantation..  26:550-551. 1994
  • Efficacy of 99mTc voiding cystourethrogram for detection of duodenal leaks after pancreas transplantation..  26:462-463. 1994
  • Efficacy of human anodal trypsinogen for detection of rejection in clinical pancreas transplantation..  26:531-533. 1994
  • Ganciclovir/acyclovir prophylaxis reduces the incidence of cytomegalovirus infections in pancreas transplant recipients..  26:432-433. 1994
  • Molecular strategies for the treatment of diabetes..  26:363-365. 1994
  • Urological complications and enteric conversion after pancreas transplantation with bladder drainage..  26:458-459. 1994
  • Changing spectrum of pediatric renal transplantation..  26:23. 1994
  • In utero transplantation of rat hematopoietic stem cells induces xenogeneic chimerism in mice..  26:126-128. 1994
  • Impact of donor factors and preservation on function and survival after liver transplantation..  25:3031-3033. 1993
  • Rat strain differences in complement activity correlate with hyperacute rejection of guinea pig cardiac xenografts..  25:2848-2849. 1993
  • Renal transplantation in the cyclosporine era.  25:15-16. 1993
  • State of the art of liver transplantation in the USA.  25:47. 1993
  • Surgical refinements in liver transplantation.  25:48-49. 1993
  • EFFECT OF CYCLOSPORINE ON RENAL-FUNCTION IN SURVIVORS OF LIVER-TRANSPLANTATION AFTER 1 YEAR.  25:13-14. 1993
  • Effect of cyclosporine on renal function in survivors of liver transplantation after 1 year..  25:13-14. 1993
  • RENAL-TRANSPLANTATION IN THE CYCLOSPORINE ERA.  25:15-16. 1993
  • Renal transplantation in the cyclosporine era..  25:15-16. 1993
  • SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION AT THE UNIVERSITY-OF-WISCONSIN.  25:33-34. 1993
  • STATE-OF-THE-ART OF LIVER-TRANSPLANTATION IN THE USA.  25:47-47. 1993
  • SURGICAL REFINEMENTS IN LIVER-TRANSPLANTATION.  25:48-49. 1993
  • Simultaneous kidney-pancreas transplantation at the University of Wisconsin..  25:33-34. 1993
  • State of the art of liver transplantation in the USA..  25:47. 1993
  • Surgical refinements in liver transplantation..  25:48-49. 1993
  • Brequinar sodium potentiates the effects of cyclosporine in experimental small bowel transplantation..  25:37-39. 1993
  • Effect of surgical and spontaneous portasystemic shunts on liver transplantation..  25:1946-1948. 1993
  • Liver transplantation in alcoholics: assessment of psychological health and work activity..  25:1916-1918. 1993
  • Update on preservation of liver grafts..  25:2010-2011. 1993
  • Effect of bursectomy on deposition of natural xenoreactive antibodies and complement within rat cardiac xenografts in the chicken..  25:435-437. 1993
  • Effects of DR mismatch on long-term graft survival in simultaneous kidney-pancreas transplantation..  25:237-238. 1993
  • Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo..  25:770-771. 1993
  • Human antiporcine mixed lymphocyte reaction..  25:442-443. 1993
  • Inhibition of tumor necrosis factor release from cultured rat Kupffer cells by agents that reduce graft failure from storage injury..  25:1631-1632. 1993
  • LIVING UNRELATED KIDNEY DONATION - AN UNDERUTILIZED RESOURCE.  25:1532-1534. 1993
  • Living unrelated kidney donation: an underutilized resource?.  25:1532-1534. 1993
  • Living-related kidney transplant or simultaneous pancreas-kidney for diabetic renal failure?.  25:230-232. 1993
  • MALFUNCTION OF THE LIVER AFTER TRANSPLANTATION - AN ANALYSIS OF POTENTIAL RISK-FACTORS.  25:1659-1661. 1993
  • Malfunction of the liver after transplantation: an analysis of potential risk factors..  25:1659-1661. 1993
  • Renal tubular cell expression of MHC class II (I-Eb) is insufficient to initiate immune injury in a transgenic kidney transplant model..  25:142-143. 1993
  • SHOULD ABDOMINAL CLUSTER TRANSPLANTATION BE ABANDONED.  25:1361-1363. 1993
  • Should abdominal cluster transplantation be abandoned?.  25:1361-1363. 1993
  • Brequinar sodium potentiates the effects of cyclosporine in experimental small bowel transplantation.  25:37-39. 1993
  • Effect of bursectomy on deposition of natural xenoreactive antibodies and complement within rat cardiac xenografts in the chicken.  25:435-437. 1993
  • Human antiporcine mixed lymphocyte reaction.  25:442-443. 1993
  • Inhibition of tumor necrosis factor release from cultured rat Kupffer cells by agents that reduce graft failure from storage injury.  25:1631-1632. 1993
  • Living unrelated kidney donation: An underutilized resource?.  25:1532-1534. 1993
  • Living-related kidney transplant or simultaneous pancreas-kidney for diabetic renal failure?.  25:230-232. 1993
  • Malfunction of the liver after transplantation: An analysis of potential risk factors.  25:1659-1661. 1993
  • Should abdominal cluster transplantation be abandoned?.  25:1361-1363. 1993
  • Simultaneous kidney-pancreas transplantation at the University of Wisconsin.  25:33-34. 1993
  • Rapamycin suppression of host-versus-graft and graft-versus-host disease in MHC-mismatched rats..  24:1174. 1992
  • Rapid translocation of bacteria in small bowel transplantation..  24:1103. 1992
  • Use of tissue blood flow and high energy phosphate content to predict small bowel graft survival..  24:1088-1089. 1992
  • Discordant complement systems as a factor in hyperacute xenograft rejection..  24:481-482. 1992
  • Effect of soluble complement receptor type 1 on natural antibody levels during xenograft rejection..  24:477-478. 1992
  • Effects of bursectomy and rat skin xenografts on natural antibodies in chickens..  24:472-473. 1992
  • IgG is a prominent component of cynomolgus antiporcine natural xenoantibody..  24:435. 1992
  • In vitro analysis of the human antiporcine T-cell repertoire..  24:602-603. 1992
  • Species differences in natural xenoantibody to swine..  24:604. 1992
  • Use of heterohybridomas in xenotransplantation..  24:457-458. 1992
  • Xenoantigens expressed on swine erythrocytes, lymphoblastoid cells, and endothelial cells..  24:593-594. 1992
  • FK 506 rescue therapy for resistant rejection episodes in liver transplant recipients..  23:2987-2988. 1991
  • Pulmonary infiltrates and eosinophilia in an FK 506 liver transplant recipient..  23:3195-3196. 1991
  • Results of combined hepatic, pancreaticoduodenal, and renal procurements..  23:2309-2311. 1991
  • Biliary tract complications after orthotopic liver transplantation..  23:1956. 1991
  • Liver retransplantation: the University of Wisconsin experience..  23:1955. 1991
  • A COMPARISON OF DONOR-SPECIFIC AND RANDOM TRANSFUSIONS IN LIVING-RELATED RENAL-TRANSPLANTATION AND THEIR EFFECT ON STEROID WITHDRAWAL.  23:1321-1322. 1991
  • A comparison of donor-specific and random transfusions in living-related renal transplantation and their effect on steroid withdrawal..  23:1321-1322. 1991
  • EFFECT OF STEROID WITHDRAWAL ON HYPERTENSION AND CHOLESTEROL LEVELS IN LIVING RELATED RECIPIENTS.  23:1363-1364. 1991
  • Effect of steroid withdrawal on hypertension and cholesterol levels in living related recipients..  23:1363-1364. 1991
  • Macrophage migration into hepatic xenografts in the hamster-to-rat combination..  23:220-221. 1991
  • OKT3 VS ALG INDUCTION THERAPY IN COMBINED PANCREAS-KIDNEY TRANSPLANTATION.  23:1581-1582. 1991
  • OKT3 vs ALG induction therapy in combined pancreas-kidney transplantation..  23:1581-1582. 1991
  • ORTHOTOPIC LIVER-TRANSPLANTATION IN PATIENTS OVER 60 YEARS OF AGE.  23:1456-1457. 1991
  • Orthotopic liver transplantation in patients over 60 years of age..  23:1456-1457. 1991
  • PREDICTIVE FACTORS FOR IMMUNOLOGICAL GRAFT FAILURE IN CADAVER RENAL-TRANSPLANT RECIPIENTS.  23:1282-1283. 1991
  • Predictive factors for immunologic graft failure in cadaver renal transplant recipients..  23:1282-1283. 1991
  • THE PREDICTIVE VALUE OF DONOR LIVER BIOPSIES ON THE DEVELOPMENT OF PRIMARY NONFUNCTION AFTER ORTHOTOPIC LIVER-TRANSPLANTATION.  23:1536-1537. 1991
  • The effect of 15-deoxyspergualin on hamster-to-rat cardiac xenograft survival..  23:585-586. 1991
  • The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation..  23:1536-1537. 1991
  • Total lymphoid irradiation for cardiac xenotransplantation in nonhuman primates..  23:587-588. 1991
  • The effect of 15-deoxyspergualin on hamster-to-rat cardiac xenograft survival.  23:585-586. 1991
  • Tubular markers in renal transplant patients under cyclosporine..  22:2277-2279. 1990
  • Experience with combined hepatic, pancreaticoduodenal, and renal procurement with UW solution..  22:2076-2077. 1990
  • Experience with reduced-size liver transplantation in infants and children..  22:1489-1491. 1990
  • Use of OKT3 in kidney, pancreas, and liver transplantation..  22:1748-1749. 1990
  • Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation..  22:1336-1338. 1990
  • Decreased kallikrein excretion in renal transplant treated with cyclosporine A..  22:294-296. 1990
  • Renal transplantation in the American black..  21:3931-3933. 1989
  • A platelet-derived growth factor homolog secreted by alveolar macrophages is complexed to an alpha-macroglobulin..  21:3704-3705. 1989
  • A synergistic effect of total lymphoid irradiation, cyclosporine, and splenectomy in a hamster-to-rat hepatic xenograft model..  21:3556. 1989
  • Chronic graft-versus-host disease, obliterative bronchiolitis, and graft-versus-leukemia effect: case histories..  21:51-62. 1989
  • Current status of bone marrow transplantation..  21:41-50. 1989
  • Regulation of biliary secretion following liver transplantation..  21:3554. 1989
  • The effect of pretreatment with class I major histocompatibility complex (MHC) antigens on hepatic or cardiac allograft survival in the rat..  21:3555. 1989
  • The role of class I antigens in hyperacute rejection of hepatic allografts in rats..  21:3557. 1989
  • Characteristics of alloreactive rat T cell lines established from low and high rejecting orthotopic liver transplants..  21:3286-3288. 1989
  • Congress review: progress and prospects in bone marrow transplantation..  21:2919-2922. 1989
  • Effects of donor splenocytes treated with mitomycin C on rat hepatic, cardiac, and intestinal allografts..  21:213-214. 1989
  • Endocrine changes and haemodynamic stability after brain death..  21:1197-1198. 1989
  • In situ and systemic cellular immunity associated with orthotopic rat liver allograft acceptance or rejection..  21:416-420. 1989
  • Long-term results of allogeneic bone marrow transplantation..  21:2926-2928. 1989
  • PERFORATION OF THE GASTROINTESTINAL-TRACT FOLLOWING RENAL-TRANSPLANTATION.  21:2143-2144. 1989
  • Perforation of the gastrointestinal tract following renal transplantation..  21:2143-2144. 1989
  • The role of RT1.a major histocompatibility antigens in prolonging the survival of hepatic allografts in the rat..  21:792-793. 1989
  • Total lymphoid irradiation and cyclosporine prolongs cardiac allograft survival in the sensitized rat model..  21:1118-1119. 1989
  • Congress review: Progress and prospects in bone marrow transplantation.  21:2919-2922. 1989
  • In situ and systemic cellular immunity associated with orthotopic rat liver allograft acceptance or rejection.  21:416-420. 1989
  • Long-term results of allogeneic bone marrow transplantation.  21:2926-2928. 1989
  • Perforation of the gastrointestinal tract following renal transplantation.  21:2143-2144. 1989
  • The role of RT1.A major histocompatibility antigens in prolonging the survival of hepatic allografts in the rat.  21:792-793. 1989
  • Total lymphoid irradiation and cyclosporine prolongs cardiac allograft survival in the sensitized rat model.  21:1118-1119. 1989
  • Cyclosporine nephrotoxicity: a workshop to discuss mechanisms, diagnosis, and treatment..  20:833-840. 1988
  • Cyclosporine therapy and the development of interstitial fibrosis in renal allografts..  20:807-811. 1988
  • In vitro and in vivo human T cell repertoire in kidney allograft rejection..  20:155-158. 1988
  • Phenotype and function of T cells propagated from donor-specific blood transfusion enhanced and autologous blood transfused rejecting rat renal allografts..  20:276-280. 1988
  • Relationships among renal allograft biopsy infiltrates, growth of T cell lines, and irreversible rejection..  20:303-305. 1988
  • ANTIBODY-TITERS AND CARDIAC ALLOGRAFT SURVIVAL IN THE SENSITIZED RAT MODEL - EFFECT OF TIME AFTER INITIAL SENSITIZATION.  20:839-841. 1988
  • Allogeneic small bowel transplantation with cyclosporine and donor whole-body irradiation..  20:193-196. 1988
  • Prolonged survival of hepatic xenografts in the hamster to rat combination: efficacy of cyclosporine in combination with splenectomy..  20:731-733. 1988
  • Allogeneic small bowel transplantation with cyclosporine and donor whole-body irradiation.  20:193-196. 1988
  • Antibody titers and cardiac allograft survival in the sensitized rat model: Effect of time after initial sensitization.  20:839-841. 1988
  • Cyclosporine therapy and the development of interstitial fibrosis in renal allografts.  20:807-811. 1988
  • Prolonged survival of hepatic xenografts in the hamster to rat combination: Efficacy of cyclosporine in combination with splenectomy.  20:731-733. 1988
  • Hemolytic anemia is not a frequent complication of ABO unmatched renal allografts from living related donors..  19:4516-4519. 1987
  • Humoral rejection of rat hepatic transplants by passive transfer of serum.  19:1072-1076. 1987
  • Associations between rat renal allograft function, inflammation, and host immunity.  19:379-381. 1987
  • Phenotype and patterns of inflammatory cell infiltration associated with rejection or acceptance of rat liver allografts.  19:364-368. 1987
  • Associations between rat renal allograft function, inflammation, and host immunity..  19:379-381. 1987
  • COMBINED TOTAL LYMPHOID IRRADIATION AND CYCLOSPORINE PROMOTE XENOGRAFT SURVIVAL.  19:1137-1139. 1987
  • Combined total lymphoid irradiation and cyclosporine promote xenograft survival..  19:1137-1139. 1987
  • Graft-versus-leukemia in the rat--the antileukemic efficacy of syngeneic and allogeneic graft-versus-host disease..  19:2668-2673. 1987
  • HUMORAL REJECTION OF RAT HEPATIC TRANSPLANTS BY PASSIVE TRANSFER OF SERUM.  19:1072-1076. 1987
  • Humoral rejection of rat hepatic transplants by passive transfer of serum..  19:1072-1076. 1987
  • PEPTIC-ULCER DISEASE FOLLOWING RENAL-TRANSPLANTATION.  19:2233-2236. 1987
  • PHENOTYPE AND PATTERNS OF INFLAMMATORY CELL INFILTRATION ASSOCIATED WITH REJECTION OR ACCEPTANCE OF RAT-LIVER ALLOGRAFTS.  19:364-368. 1987
  • Peptic ulcer disease following renal transplantation..  19:2233-2236. 1987
  • Phenotype and patterns of inflammatory cell infiltration associated with rejection or acceptance of rat liver allografts..  19:364-368. 1987
  • Results of the South-Eastern Organ Procurement Foundation strategy for transplanting sensitized patients..  19:1964-1966. 1987
  • Transfusion effect on graft-versus-host disease and leukemic relapse in HLA-matched bone marrow transplantation..  19:2700. 1987
  • Combined total lymphoid irradiation and cyclosporine promote xenograft survival.  19:1137-1139. 1987
  • Cytotoxic lymphocyte precursor frequency and cell-mediated lympholysis responses between major histocompatibility complex-disparate rat strains.  19:3050-3053. 1987
  • Discordant effects of donor-specific blood transfusions on host alloimmune responses and rat renal allograft function.  19:3072-3075. 1987
  • Renal allograft function, arachidonic acid metabolism, and systemic cellular immunity after kidney transplantation in the rat.  19:3116-3118. 1987
  • The appearance of major histocompatibilit y complex class II antigens in rat small bowel allograft-induced graft-versus-host disease.  19:3019-3021. 1987
  • The role of modified self in the induction of antigen-specific suppressor cells in the rat.  19:3082-3084. 1987
  • Antithymocyte globulin followed by cyclosporine for the treatment of acute GVHD in patients given HLA-identical or -nonidentical marrow grafts.  18:791-793. 1986
  • Influence of donor-specific blood transfusions on host cellular immune responsiveness.  18:692-694. 1986
  • Lipid mediators in acute renal allograft rejection.  18:94-97. 1986
  • Monitoring the donor-specific response of renal transplant patients by needle biopsy and long-term culture of alloreactive T-cell clones.  18:748-749. 1986
  • Temporary occlusion of the portal vein in the rat.  18:1220. 1986
  • The impact of donor renal abnormalities in cadaver transplantation.  18:459-462. 1986
  • Cardiac transplantation without a prospective crossmatch.  17:209-211. 1985
  • Comparison of cyclosporine and conventional immunosuppressive therapy in renal transplantation: A prospective multicenter study.  17:2196-2201. 1985
  • Phenotype and pattern of renal allograft cellular infiltrates associated with subsequent irreversible rejection.  17:2614-2616. 1985
  • RENAL-TRANSPLANT MONITORING WITH SERUM BETA-2-MICROGLOBULIN AND CREATININE.  17:646-651. 1985
  • Renal transplant monitoring with serum β-2-microglobulin and creatinine.  17:646-651. 1985
  • Renal transplant wastage: An international problem.  17:1594-1596. 1985
  • Transplantation tolerance produced with histocompatibility antigen-cell conjugates.  15:828-830. 1983
  • The relationship of transfusion and presensitization with graft and patient survival..  14:287-289. 1982
  • Renal transplantation in highly sensitized patients.  14:46-48. 1982
  • Unique immunologic problems in human bone marrow transplant recipients..  13:1624-1627. 1981
  • Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation..  13:248-251. 1981
  • Orthopedic complications of renal transplantation in children..  11:104-106. 1979
  • Mixed lymphocyte responses in a four-generation C2 deficiency family..  9:1733-1735. 1977
  • Statistical methods for evaluating responses in HLA-D typing..  9:99-106. 1977
  • Transplantation in miniature swine..  9:575-577. 1977
  • Histocompatibility testing in chimpanzee families..  6:129-134. 1974
  • Immunologic studies on T and B lymphocytes in chimpanzees: effects of thymectomy and irradiation..  6:183-188. 1974
  • Mixed-lymphocyte-culture responses in chimpanzee families..  6:135-139. 1974
  • Summary of the proceedings of the second international workshop on transplantation genetics of nonhuman primates..  6:223-227. 1974
  • Mixed lymphocyte reactions and skin graft survival in an HL-A recombinant family..  5:359-362. 1973
  • Renal transplantation between histocompatible donor-recipient pairs..  4:439-446. 1972
  • The rehabilitation of renal allograft recipients..  4:755-757. 1972
  • Characterization of chimpanzee leukocyte alloantisera..  4:49-54. 1972
  • Cytotoxicity reactions of chimpanzee antisera with human lymphocyte donors phenotyped or genotyped for HL-A..  4:63-69. 1972
  • Joint report of first histocompatibility workshop on primates..  4:141-147. 1972
  • Reactions of human HL-A sera with orangutan and gorilla lymphocytes..  4:83-86. 1972
  • Selection of donors for kidney transplantation..  3:993-1003. 1971
  • Anomalous MLR responsiveness among siblings..  3:118-120. 1971
  • Comparisons of mixed leukocyte reactions with skin graft survival in families genotyped for HL-A..  3:115-117. 1971
  • Tissue antigens of man and chimpanzees; their role in xenografting..  2:463-467. 1970
  • Skin graft rejection between subjects genotyped for HL-A..  1:342-346. 1969
  • Erratum.  44:309-309. 2012
  • The 10th international hand and composite allotransplantation society (IHCTAS).  43:3500. 2011
  • Incidence and management of Kaposi sarcoma in renal transplant recipients: the Greek experience. 2014
  • Lithiasis of the renal allograft, a rare urological complication following renal transplantation: a single-center experience of 2,045 renal transplantations. 2014
  • Single-center experience of transplantation for polycystic liver disease. 2014
  • Safety and efficacy of living donor liver preservation with HTK solution. 2005
  • Delayed cardiac xenograft rejection in a pig-to-baboon model treated with a tolerance-inducing regimen and donor bone marrow infusion. 2000
  • Effects of pretransplant splenectomy and immunosuppression of humoral immunity in a pig-to-newborn goat cardiac xenograft model. 2000
  • Leukocyte response to thymoglobulin or atgam for induction immunosuppression in a randomized, double-blind clinical trial in renal transplant recipients. 1999
  • A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up. 1999
  • Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients. 1999
  • Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients. 1999
  • Utilization of pediatric donors for pancreas transplantation. 1999
  • Effects of immunosuppression and pretransplant splenectomy in newborn cardiac xenograft survival. 1998
  • Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression. 1998
  • Outcome of kidney transplantation in African-Americans using tacrolimus. 1997
  • Influence of donor criteria on early outcome after intestinal transplantation. 1997
  • Infectious complications after small bowel transplantation in adults: an update. 1996
  • Tacrolimus in renal transplantation. 1996
  • Expression of newborn pig endothelial cell xenoantigens recognized by baboon natural xenoantibody. 1996
  • Newborn discordant cardiac xenotransplantation in primates: a model of natural antibody depletion. 1996
  • Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation. 1995
  • A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. 1995
  • Circulating donor antigen and response to donor antigen as predictors of long-term lung and kidney transplant success. 1995
  • One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. 1995
  • Posttransplant B, non-A non-B, and cytomegalovirus hepatitis increase the risk of developing chronic rejection after liver transplantation. 1995
  • Renal transplantation under cyclosporine and FK 506 for hemolytic uremic syndrome. 1995
  • Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation. 1995
  • Factors associated with recurrent cytomegalovirus disease after small bowel transplantation. 1994
  • Identification and functional analysis of human natural anti-pig xenoantibodies. 1994
  • Infectious complications after small bowel transplantation in adults. 1994
  • Prolonged survival of pig cardiac xenografts in unmodified newborn baboons. 1994
  • Pediatric kidney transplantation at the University of Pittsburgh. 1994
  • Can adenine nucleotides predict primary nonfunction of the human liver homograft? 1993
  • Effect of cyclosporine on renal function in survivors of liver transplantation after 1 year 1993
  • Effect of recipient race on waiting time for renal transplantation at the University of Pittsburgh. 1993
  • Posttransplant hypertension in blacks versus nonblacks. 1993
  • Renal transplantation under FK 506 in African-Americans: early experience. 1993
  • BREQUINAR SODIUM POTENTIATES THE EFFECTS OF CYCLOSPORINE IN EXPERIMENTAL SMALL-BOWEL TRANSPLANTATION 1993
  • Adverse effects of FK 506 overdosage after liver transplantation. 1993
  • Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. 1993
  • Effect of intraportal human islet transplantation on kidney graft survival in simultaneous kidney-islet allografts. 1993
  • Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report. 1993
  • Effects of DR mismatch on long-term graft survival in simultaneous kidney- pancreas transplantation 1993
  • Lymphocyte xenoantigens recognized by preformed antibodies. 1992
  • Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation. 1992
  • Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients. 1991
  • Evaluation of a novel "intelligent" dosing system for optimizing FK 506 therapy. 1991
  • Metabolic effects of FK 506 in patients with severe psoriasis: short-term follow-up of seven cases. 1991
  • THE EFFECT OF 15-DEOXYSPERGUALIN ON HAMSTER-TO-RAT CARDIAC XENOGRAFT SURVIVAL 1991
  • A comparison of donor-specific and random transfusions in living-related renal transplantation and their effect on steroid withdrawal 1991
  • Effect of steroid withdrawal on hypertension and cholesterol levels in living related recipients 1991
  • Macrophage migration into hepatic xenografts in the hamster-to-rat combination 1991
  • OKT3 vs ALG induction therapy in combined pancreas-kidney transplantation 1991
  • Orthotopic liver transplantation in patients over 60 years of age 1991
  • Predictive factors for immunologic graft failure in cadaver renal transplant recipients 1991
  • The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation 1991
  • Total lymphoid irradiation for cardiac xenotransplantation in nonhuman primates 1991